10591291|t|Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.
10591291|a|BACKGROUND: Increasing plasma glucose levels improves memory in patients with Alzheimer disease (AD). Increasing plasma glucose levels also increases endogenous insulin levels, raising the question of whether memory improvement is due to changes in insulin, independent of hyperglycemia. We address this question by examining memory and counterregulatory hormone response during hyperglycemia when endogenous insulin was suppressed by concomitant infusion of the somatostatin analogue octreotide (Sandostatin). METHODS: Twenty-three patients with AD and 14 similarly aged healthy adults participated in 4 metabolic conditions on separate days: (1) hyperinsulinemia (538 pmol/L) with fasting glucose (5.6 mmol/L [100 mg/dL]), achieved by insulin and variable dextrose infusion; (2) hyperglycemia (12.5 mmol/L [225 mg/dL]) with fasting insulin (57 pmol/L), achieved by dextrose and somatostatin (octreotide) infusion (150 mg/h); (3) placebo with isotonic sodium chloride solution (saline) infusion (fasting insulin and glucose); and (4) an active control condition in which somatostatin alone was infused (150 mg/h). Declarative memory (story recall) and selective attention (Stroop interference test) were measured during steady metabolic states. RESULTS: Patients with AD showed improved memory during hyperinsulinemia relative to placebo (P = .05) and relative to hyperglycemia (P<.005). Memory did not improve during hyperglycemia when insulin was suppressed. Somatostatin analogue infusion alone also improved memory for patients with AD (P<.05). Hyperinsulinemia increased cortisol levels in subjects with AD, whereas somatostatin alone lowered cortisol concentrations. CONCLUSIONS: These results confirm that elevated insulin without hyperglycemia enhances memory in adults with AD, and indicate that insulin is essential for hyperglycemic memory facilitation. These results also suggest a potential therapeutic role for somatostatin in AD.
10591291	25	42	Alzheimer disease	Disease	MESH:D000544
10591291	48	55	insulin	Gene	3630
10591291	60	72	somatostatin	Gene	6750
10591291	82	89	glucose	Chemical	MESH:D005947
10591291	121	128	glucose	Chemical	MESH:D005947
10591291	155	163	patients	Species	9606
10591291	169	186	Alzheimer disease	Disease	MESH:D000544
10591291	188	190	AD	Disease	MESH:D000544
10591291	211	218	glucose	Chemical	MESH:D005947
10591291	252	259	insulin	Gene	3630
10591291	340	347	insulin	Gene	3630
10591291	364	377	hyperglycemia	Disease	MESH:D006943
10591291	470	483	hyperglycemia	Disease	MESH:D006943
10591291	500	507	insulin	Gene	3630
10591291	554	566	somatostatin	Gene	6750
10591291	576	586	octreotide	Chemical	MESH:D015282
10591291	588	599	Sandostatin	Chemical	MESH:D015282
10591291	624	632	patients	Species	9606
10591291	638	640	AD	Disease	MESH:D000544
10591291	739	755	hyperinsulinemia	Disease	MESH:D006946
10591291	782	789	glucose	Chemical	MESH:D005947
10591291	828	835	insulin	Gene	3630
10591291	849	857	dextrose	Chemical	MESH:D005947
10591291	872	885	hyperglycemia	Disease	MESH:D006943
10591291	925	932	insulin	Gene	3630
10591291	958	966	dextrose	Chemical	MESH:D005947
10591291	971	983	somatostatin	Gene	6750
10591291	985	995	octreotide	Chemical	MESH:D015282
10591291	1044	1059	sodium chloride	Chemical	MESH:D012965
10591291	1096	1103	insulin	Gene	3630
10591291	1108	1115	glucose	Chemical	MESH:D005947
10591291	1163	1175	somatostatin	Gene	6750
10591291	1346	1354	Patients	Species	9606
10591291	1360	1362	AD	Disease	MESH:D000544
10591291	1393	1409	hyperinsulinemia	Disease	MESH:D006946
10591291	1456	1469	hyperglycemia	Disease	MESH:D006943
10591291	1510	1523	hyperglycemia	Disease	MESH:D006943
10591291	1529	1536	insulin	Gene	3630
10591291	1553	1565	Somatostatin	Gene	6750
10591291	1615	1623	patients	Species	9606
10591291	1629	1631	AD	Disease	MESH:D000544
10591291	1641	1657	Hyperinsulinemia	Disease	MESH:D006946
10591291	1668	1676	cortisol	Chemical	MESH:D006854
10591291	1701	1703	AD	Disease	MESH:D000544
10591291	1713	1725	somatostatin	Gene	6750
10591291	1740	1748	cortisol	Chemical	MESH:D006854
10591291	1814	1821	insulin	Gene	3630
10591291	1830	1843	hyperglycemia	Disease	MESH:D006943
10591291	1875	1877	AD	Disease	MESH:D000544
10591291	1897	1904	insulin	Gene	3630
10591291	1922	1935	hyperglycemic	Disease	MESH:D006944
10591291	2017	2029	somatostatin	Gene	6750
10591291	2033	2035	AD	Disease	MESH:D000544
10591291	Association	MESH:D005947	MESH:D000544
10591291	Positive_Correlation	MESH:D006854	MESH:D006946
10591291	Association	MESH:D000544	6750
10591291	Negative_Correlation	MESH:D006854	6750
10591291	Association	MESH:D005947	3630
10591291	Negative_Correlation	MESH:D015282	6750
10591291	Positive_Correlation	MESH:D015282	MESH:D006943
10591291	Association	MESH:D006944	3630

